Tuca Zbarcea & Asociatii has advised the Amethyst Radiotherapy Group on the sale and lease-back of three buildings to the BT Property Alternative Real Estate Investment Fund.
KSB Helps Establish Eva Pavlova and Vaclav Cigler Endowment Funds
Kocian Solc Balastik has advised on the establishment of two endowment funds in the Czech Republic: Eva Pavlova’s Endowment Fund and Vaclav Cigler’s Endowment Fund.
RTPR and PeliPartners Advise on Black Sea Fund Acquisition of Gymboland
RTPR has advised the Black Sea Fund on its acquisition of Gymboland in Romania. PeliPartners advised Gymboland.
Clifford Chance Advises KKCG on Acquisition of Avenga
Clifford Chance has advised KKCG on the acquisition of the end-to-end software engineering and consulting platform Avenga from funds managed by Oaktree Capital Management and Cornerstone Investment Management.
Baker McKenzie Advises on R&S Group Public Listing on SIX Swiss Exchange
Baker McKenzie has advised the VT5 Acquisition Company – a SIX-listed Swiss special purpose acquisition company – on the acquisition of R&S International Holding AG, an agreed business combination to take the R&S Group public on the SIX Swiss Exchange. Swiss law firm Advestra advised sole global coordinator UBS and joint bookrunner ZKB.
Turunc and Kutadgu & Arsin Advise on Brandefense Investment Round
Turunc has advised Gelecek Etki Fonu on its investment in Brandefense in a round that included Sabanci Ventures, AK Portfoy, the Technology Development Foundation of Turkiye, TechOne, and Finberg. Kutadgu & Arsin advised Brandefense. Reportedly, BASEAK and the Diamond Law Group advised Sabanci Ventures, while BTS advised the Technology Development Foundation of Turkiye.
Schoenherr Advises Ceres Pharma on Acquisition of Innopharm & VitaPlus in Hungary
Schoenherr has advised Ceres Pharma on the acquisition of the Hungarian pharmaceutical companies VitaPlus and Innopharm, including their Innopharm Austrian subsidiary.